Costa-Requena Gema, Ballester Arnal Rafael, Gil Francisco
Clinical Psychology, Department of Psychiatry, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, CIBERSAM, Barcelona, Spain.
Stress Health. 2013 Dec;29(5):421-6. doi: 10.1002/smi.2488. Epub 2013 Feb 25.
This study examines differences in perceived social support during oncology treatment of cancer patients, whilst taking into account the presence of psychiatric disorder. Of particular interest were cancer patients who received psychopharmacology treatment compared with those who did not. A total of 760 cancer outpatients were recruited from one hospital in Spain. Multivariate analysis of variance with the general linear model procedure was used. The Medical Outcomes Study Social Support Survey was used to assess social support perceived. The Diagnostic Interview Schedule using DSM-III-R criteria was utilized for the diagnosis of psychiatric disorders. There were significant differences between the patients diagnosed with a psychiatric disorder and those not diagnosed with psychiatric disorders in terms of perceived Emotional/Informational Support (F = 19.11, p < 0.01), Affectionate Support (F = 12.30, p < 0.01) and the Overall Support Index (F = 16.73, p < 0.01). In patients requiring psychopharmacology treatment, significant differences were presented with Structural Support (F = 4.32, p < 0.05), Emotional/Informational Support perceived (F = 7.87, p < 0.01), Instrumental Support (F = 4.17, p < 0.05) and Overall Support Index (F = 7.84, p < 0.01). Psychopharmacology treatment helped to increase the perception of social support received by the patient. Healthcare professionals could provide support that would normalize cancer patients' distress, taking into account the importance of perceived social support for the psychological well-being of patients.
本研究考察了癌症患者在肿瘤治疗期间所感受到的社会支持差异,同时考虑到精神障碍的存在。特别令人感兴趣的是接受精神药理学治疗的癌症患者与未接受该治疗的患者之间的差异。从西班牙的一家医院招募了760名癌症门诊患者。使用一般线性模型程序进行多变量方差分析。采用医学结果研究社会支持调查来评估所感受到的社会支持。使用基于《精神疾病诊断与统计手册》第三版修订版(DSM-III-R)标准的诊断访谈表来诊断精神障碍。在感受到的情感/信息支持(F = 19.11,p < 0.01)、亲情支持(F = 12.30,p < 0.01)和总体支持指数(F = 16.73,p < 0.01)方面,被诊断患有精神障碍的患者与未被诊断患有精神障碍的患者之间存在显著差异。在需要精神药理学治疗的患者中,在结构支持(F = 4.32,p < 0.05)、感受到的情感/信息支持(F = 7.87,p < 0.01)、工具性支持(F = 4.17,p < 0.05)和总体支持指数(F = 7.84,p < 0.01)方面存在显著差异。精神药理学治疗有助于提高患者所感受到的社会支持。医疗保健专业人员可以提供支持,使癌症患者的痛苦正常化,同时考虑到所感受到的社会支持对患者心理健康的重要性。